SALL4 and hepatocellular carcinoma: To determine the specificity of miR-200c interacting with SALL4 or PD-L1, we examined the expression of miR-200a and miR-383 which might target PD-L1 as shown in Fig. 1a, and analyzed their association with SALL4 and PD-L1 expression in HCC patients.